QuiVad
My list

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on September 22, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.19%newSeptember 22, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

439 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 19, 2021Capital Fund Management SA0.00%
July 16, 2021Consonance Capital Management LP0.91%
July 16, 2021Citadel Advisors LLC0.85%
July 16, 2021Arrowstreet Capital Limited Partnership0.73%
July 16, 2021Marshall Wace LLP0.71%
July 16, 2021Capital Fund Management SA0.51%
July 15, 2021Worldquant LLC0.86%
July 15, 2021Citadel Advisors LLC0.78%
July 15, 2021Consonance Capital Management LP0.64%
July 15, 2021Marshall Wace LLP0.56%
July 14, 2021Citadel Advisors LLC0.80%
July 14, 2021Worldquant LLC0.79%
July 13, 2021Mangrove Partners0.79%
July 13, 2021Worldquant LLC0.56%
July 9, 2021Mangrove Partners0.58%
July 8, 2021Adage Capital Management LP0.88%
July 8, 2021Citadel Advisors LLC0.75%
July 7, 2021Arrowstreet Capital Limited Partnership0.62%
June 28, 2021Citadel Advisors LLC0.80%
June 23, 2021Arrowstreet Capital Limited Partnership0.50%
June 22, 2021Citadel Advisors LLC0.71%
June 15, 2021Arrowstreet Capital Limited Partnership0.00%
June 7, 2021Citadel Advisors LLC0.62%
June 3, 2021Citadel Advisors LLC0.52%
May 26, 2021Arrowstreet Capital Limited Partnership0.54%
April 7, 2021Voleon Capital Management LP0.00%
March 30, 2021Voleon Capital Management LP0.58%
March 29, 2021Voleon Capital Management LP0.66%
March 18, 2021Voleon Capital Management LP0.70%
March 12, 2021Voleon Capital Management LP0.61%
March 11, 2021Voleon Capital Management LP0.53%
February 8, 2021POINT72 Asset Management LP0.00%
November 20, 2020Point72 Asset Management LP0.72%
October 12, 2020Point72 Asset Management LP0.60%
September 17, 2020Voleon Capital Management LP0.00%
September 16, 2020Voleon Capital Management LP0.54%
September 15, 2020Voleon Capital Management LP0.60%
September 11, 2020Point72 Asset Management LP0.52%
September 4, 2020Voleon Capital Management LP0.71%
September 2, 2020Voleon Capital Management LP0.50%
July 29, 2020Voleon Capital Management LP0.00%
July 28, 2020Voleon Capital Management LP0.50%
July 24, 2020Voleon Capital Management LP0.00%
July 20, 2020Voleon Capital Management LP0.59%
July 13, 2020Voleon Capital Management LP0.69%
July 7, 2020Voleon Capital Management LP0.79%
July 3, 2020Voleon Capital Management LP0.80%
June 30, 2020Voleon Capital Management LP0.77%
June 22, 2020Voleon Capital Management LP0.88%
June 11, 2020Voleon Capital Management LP0.98%

Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=8